A number of gram-negative animal-and plant-interacting bacteria use a common type III secretion system (TTSS) to secrete proteins across the bacterial envelope and to translocate antihost virulence effectors into host cells [1, 2] . Translocation of antihost effectors into target cells is facilitated by a collection of translocon components [1, 2] . Presumably, this apparatus is a multiprotein complex that forms a channel in the eukaryotic membrane through which effector proteins pass into the cytosol of the infected cell. In pathogenic Yersinia species, channel formation is implied by the organism's ability to generate contact-dependent, bacteria-induced lytic activity toward erythrocytes and macrophages [3] [4] [5] . The fact that Yersinia-induced erythrocyte lysis
A number of gram-negative animal-and plant-interacting bacteria use a common type III secretion system (TTSS) to secrete proteins across the bacterial envelope and to translocate antihost virulence effectors into host cells [1, 2] . Translocation of antihost effectors into target cells is facilitated by a collection of translocon components [1, 2] . Presumably, this apparatus is a multiprotein complex that forms a channel in the eukaryotic membrane through which effector proteins pass into the cytosol of the infected cell. In pathogenic Yersinia species, channel formation is implied by the organism's ability to generate contact-dependent, bacteria-induced lytic activity toward erythrocytes and macrophages [3] [4] [5] . The fact that Yersinia-induced erythrocyte lysis depends on Yersinia outer protein (Yop) B, YopD, and LcrV corroborates their essential role in Yop effector translocation [6] . Both YopB and YopD could also be secreted directly into liposomes, and, when these were fused with planar lipid bilayers, current fluxes that indicated transmembrane channel formation were induced [7] . However, this was contradicted recently by the lack of current fluctuations after the addition of purified YopB or YopD to lipid bilayers [5] . In fact, this latter assay was used to highlight LcrV as the core component of a translocation channel that might be stabilized by an interaction with membrane-associated YopB and YopD [5] . Reflecting this likely association, LcrV, YopB, and YopD are all encoded within the lcrGVHyopBD operon (figure 1) [8] , and antibodies directed against certain epitopes of LcrV can provide passive protection against Yersinia infections by blocking the translocation of Yop effector proteins [9] [10] [11] .
Of interest, the opportunistic pathogen Pseudomonas aeruginosa encodes a homologous operon, denoted pcrGVHpopBD (figure 1), which suggests that this pathogen uses a similar strategy for effector translocation [12] . Indeed, P. aeruginosa-mediated lysis of erythrocytes depends on PopB, PopD, and PcrV [13] , which, (pcrGVHpopBD) . The amino acid identities shared by each corresponding product are indicated [12] .
like their Yersinia counterparts-YopB, YopD, and LcrV, respectively-are essential for the translocation of antihost effector proteins into target cells [14, 15] . Like LcrV, purified PcrV induces pore formation when it is applied to planar lipid bilayers [5] , and polyclonal antibodies directed against PcrV perturb the translocation of type III toxins during P. aeruginosa infection [14, 16] . Significantly, components of the Yersinia and P. aeruginosa translocon operons are functionally interchangeable [10, 17, 18] .
Although PcrV can functionally complement an lcrV null mutant of Y. pseudotuberculosis with respect to Yop synthesis and secretion [10] , the Yersinia effectors YopE and YopH were poorly translocated [5] . This phenomenon correlated with PcrV, inducing smaller pores in the membranes of infected erythrocytes and causing smaller stepwise conductivity changes when purified protein was applied to planar lipid bilayers [5] . However, other possibilities governing the translocation efficiencies could not be excluded. It is possible that PcrV from P. aeruginosa might be less efficient at recognizing and translocating the Yersinia substrates (Yops), compared with its ability to recognize and translocate native P. aeruginosa substrates (exoenzymes). To investigate the contribution of substrate recognition in LcrV-or PcrV-dependent translocation, we measured the extent of the cytotoxins exoenzyme S (ExoS) of P. aeruginosa or YopE of Yersinia, after they had been translocated inside HeLa cell monolayers by a specially engineered Y. pseudotuberculosis strain devoid of Yop effectors but expressing either LcrV or PcrV. In addition, we considered that fully functional PcrV produced from Yersinia might require coproduction with native P. aeruginosa translocon components. To this end, we extensively characterized a full-operon deletion of lcrGVHyopBD in Y. pseudotuberculosis complemented with the corresponding pcrGVHpopBD operon of P. aeruginosa. Our results ruled out a role for LcrV/PcrV-mediated substrate recognition during translocation by Yersinia and also highlighted the need for species-specific LcrV-or PcrV-protein interactions for the optimal function of this virulence strategy during Yersinia or Pseudomonas infections.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and plasmids used in the present study are listed in table 1. Escherichia coli strains were grown in Luria Bertini broth (LB) or on Luria agar plates. Unless otherwise stated, Yersinia strains were routinely grown in LB. For growth on solid media, Yersinia-selective agar base (Difco) or blood agar base (Merck) was used. Where appropriate, the antibiotics ampicillin (100 mg/mL), kanamycin (50 mg/mL), chloramphenicol (25 mg/mL), and gentamicin (Gm; 20 mg/mL) were used.
DNA methods. Isolation of plasmid DNA from E. coli strains was done using the High Purification Plasmid Miniprep kit (Roche Applied Science). Standard DNA manipulation techniques, including the use of restriction enzymes, in vitro DNA cloning, and transformations were done essentially as described elsewhere [26] . Genelute minus EtBr spin columns (Sigma) were used to recover DNA fragments from agarose. DNA sequencing reactions were done using the DYEnamic ET terminator cycle-sequencing kit (Amersham Biosciences), and products were analyzed with an ABI Prism 377 DNA sequencer (Amersham Pharmacia Biotech).
Construction of plasmids and in-frame deletion mutants. Generation of the mutagenesis vector pAH70, which was used to construct the in-frame DlcrV mutation in the parental strains YPIII/pIB29ME and YPIII/pIB29MEK, has been described elsewhere [10] . The mutagenesis vector used to construct the inframe DyopB mutation in the same parental strains was developed as follows: polymerase chain reaction (PCR)-amplified DNA fragments were generated by overlap PCR [27] , using wild-type Yersinia YPIII/pIB102 as the template and PCR primers A, 5 -AAG TGA CAC TAG TGA GCA ACT CTA CTC T-3 (SpeI); B, 5 -TGG CGT TGA GCG GTC ATG G-3 ; C, 5 -GAC CGC TCA ACG CCA ACT GTT TAA GTT TAA GGA  GGA A-3 ; and D, 5 -TCA TCA GTC TAG AAC CGC TGA  CCA TCT C-3 (XbaI) . The resulting 780-bp fragment contained sequences flanking the yopB gene, with an in-frame deletion of codons 13-399. This fragment was cloned into SpeIXbaI-digested pDM4 [22] , which gave rise to pMF463. Construction of the mutagenesis vector pJEB35, which was used to create the in-frame DlcrGVHyopBD operon null-mutant YP-III/pIB799 and the DyopHMEKlcrGVHyopBD mutant YPIII/ pIB799-29MEK, was similarly developed using the primer combination A, 5 -GCA TGT CTC GAG GCT TAC CGA ACA TGG CTT GG-3 (XhoI); B, 5 -ATG GGA AGA TTT CAT AAT TAC CT-3 ; C, 5 -TTA TGA AAT CTT CCC AT GGT GTT GTC TGA CCA-3 ; and D, 5 -AAT ACC TCT AGA ATC GTA TCG AGT C-3 (XbaI). The resulting 1115-bp fragment contained sequence flanking upstream of lcrG and downstream of yopD with an in-frame deletion of lcrGVHyopBD. This fragment was cloned into XhoI-XbaI-digested pDM4 generating pJEB35. All mutagenesis vectors were introduced into E. coli S17-1lpir for conjugal mating experiments with Y. pseudotuberculosis. Selection for appropriate allelic exchange events to generate the deletion mutants has been described elsewhere [22] . All engineered mutant strains were verified by PCR, sequencing, and Western blot analysis.
To facilitate the maintenance of the orf1 + /exoS + (pTS103) and yerA + /yopE + (pAF19) plasmids in Yersinia, a gentamicin resistance marker was introduced in the following way. After digestion of p34S-Gm [25] with Ecl136II/SstI (MBI Fermentas), a DNA fragment corresponding to the intact gentamicin cassette was isolated and subsequently cloned into the ScaI site of the pUC19 derivates, generating pTS103-Gm and pAF19-Gm, respectively. Magnesium oxalate (MOX) test. The plating frequencies of the different mutant strains grown under high-and low-Ca 2+ conditions at 37ЊC were determined as described elsewhere [8] .
Analysis of Yop synthesis. Induction of Yop synthesis and secretion by Y. pseudotuberculosis was done using the method of Bergman et al. [8] , with the exception that, to induce ex-pression from alleles under the control of the P tac promoter, 0.4 mmol isopropyl-b-D-thiogalactopyranoside (IPTG; Sigma) was added at the time of temperature up-shift. Total and secreted protein samples were collected as described elsewhere [28] and analyzed using Western blotting coupled to detection with the enhanced chemiluminescence (ECL) system, as directed by the manufacturer (Amersham).
Cultivation of HeLa cells and the cytotoxicity assay. The human epithelial cell line HeLa was used in all in vitro infection experiments. Culture maintenance and infections with Yersinia essentially followed the guidelines of Sundin et al. [29] , except that IPTG (0.4 mmol) was added to both bacteria and cell monolayers prior to infection. The cytotoxicity of infected HeLa cells was monitored by light microscopy, and images were collected at successive time points.
Ras modification assay. Y. pseudotuberculosis strains expressing ExoS from pTS103-Gm were grown as described in the cytotoxicity assay and tested for their ability to induce the ExoS-mediated modification of eukaryotic Ras in infected HeLa cells, using the method of Sundin et al. [15] . Modification of Ras was visualized by ECL Western blot using an anti-Ras monoclonal antibody (Transduction Laboratories).
Contact hemolysis of sheep erythrocytes. Y. pseudotuberculosis strains and sheep erythrocytes (SVA) were treated as described elsewhere [5] , with the exception that IPTG (0.4 mmol) was present throughout the infection. To initiate the hemolysis assay in a round-bottomed 96-well tissue culture plate (Sarstedt), 100 mL of the erythrocyte suspension was mixed with 100 mL of bacterial culture adjusted to an OD 600 of 0.9, followed by centrifugation at 411 g for 5 min. After a 3-h incubation at 37ЊC, the pellets were carefully resuspended prior to centrifugation at 411 g for 20 min, and then 100 mL of each supernatant was transferred to a flat-bottomed 96-well tissue culture plate (Sarstedt). The release of hemoglobin was measured at l 540 nm using an iEMS reader MF (Labsystems) and expressed as lytic activity ϫ10
Ϫ2
. Contact hemolytic assays in the presence of carbohydrates was done using 30 mmol of raffinose, dextrin 15, or dextran 4 [30, 31] .
RESULTS

Construction and characterization of a Yersinia multiple Yop effector mutant devoid of LcrV or YopB.
We were interested in whether substrate specificity could account for a PcrVmediated delay in translocation by Yersinia [5] . In this scenario, PcrV would be more efficient in translocating P. aeruginosa substrates (exoenzymes) than Yersinia-derived substrates (Yops), and vice versa. We engineered a full-length deletion of codons 10-313 of LcrV in Y. pseudotuberculosis that was defective for several translocated Yop effectors (YopH, YopM, and YopE; YPIII/pIB29ME) [20] . This ensured a clean system for our translocation studies. Loss of LcrV production and secretion in YPIII/pIB29MEV was confirmed by the analysis of protein content in total and cleared supernatant fractions by Western blot analysis that used anti-LcrV antiserum (data not shown). Not surprisingly, the lcrV mutant was also typically down-regulated for the synthesis and secretion of other Yops (data not shown) [6] . Functionally complemented strains of the lcrV null mutant were established by introducing plasmids harboring genes encoding either LcrV (pTB7) or PcrV (pLJ33) under control of the IPTG-inducible P tac promoter, generating YPIII/ pIB29MEV, pTB7 and YPIII/pIB29MEV, pLJ33, respectively.
Because YopB is also an essential component of the translocase apparatus [6] , for control purposes we engineered a fulllength deletion of codons 13-399 of YopB in Y. pseudotuberculosis YPIII/pIB29ME. This DYopB 13-399 strain was termed YPIII/pIB29MEB. Significantly, the yopB null mutant lacked YopB production but was comparable to parental bacteria with respect to the production and secretion of other Yops (data not shown). This phenotype is consistent with YopB not being involved in maintaining yop regulatory control [3, 18, 32] .
LcrV and PcrV form different-sized pores in erythrocyte membranes. Pathogenic Yersinia species induce channel formation in target cell membranes, which were conveniently visualized by contact-dependent, bacteria-induced lytic activity toward erythrocytes and macrophages [3] [4] [5] 33] . Because this activity is dependent on the translocon components LcrV, YopB, and YopD, these proteins are assumed to form a pore in the target cell membrane through which the Yop effector proteins are delivered into the eukaryotic cell. We used an osmoprotectant assay [3, 5, 33] to measure the size of LcrV and PcrV pores formed after infection with Y. pseudotuberculosis. Suitably sized osmoprotectants will block a pore to prevent osmotic lysis of the erythrocytes, which can be quantified by measuring the release of hemoglobin at OD 540 [5, 33] . Because wild-type Y. pseudotuberculosis normally induces low lytic activity on erythrocytes, the assay sensitivity was increased by incorporating a yopK deletion into our bacterial strains. Of importance, a loss of YopK is known to increase lytic levels without altering the pattern of Yop synthesis (data not shown) [5, 33] . Therefore, the resulting parental strains YPIII/pIB29MEK, YPIII/pIB29MEKV, and YPIII/pIB29MEKB were used in our osmoprotection assay. After the infection of sheep erythrocytes, a pronounced lytic activity was induced by strains expressing LcrV in cis (figure 2A, YPIII/pIB29MEK) and in trans (figure 2B; YPIII/ pIB29MEKV, pTB7). Moreover, only the largest carbohydrate, dextran 4 (3-3.5 nm diameter [f]), could significantly inhibit this activity ( , 58% reduction). Neither raffinose (1.2-1.4 P ! .05 nm f) nor dextrin 15 (2.2 nm f) significantly blocked the lysis through LcrV-mediated pores. In contrast, the lytic activity associated with Yersinia expressing PcrV in trans ( figure 2C ; YP-III/pIB29MEKV, pLJ33) was dramatically reduced, compared with that of an isogenic strain expressing LcrV (∼7-fold reduction). Furthermore, the smaller carbohydrates raffinose and dextrin 15 significantly ( ) blocked the PcrV-mediated P ! .05 pores by 21% and 39%, respectively. In the presence of dextran 4, almost complete blockage (96% inhibition) was obtained. These results are consistent with the idea that PcrV formed smaller pores. Analogous with their requirement for effector translocation, the YopB-defective strain YPIII/pIB29MEKB (figure 2A) and the LcrV-defective strain YPIII/pIB29MEKV (figure 2B and 2C) did not induce erythrocyte lysis.
Neither LcrV nor PcrV exhibits a preference for YopE or ExoS translocation by Y. pseudotuberculosis. Having established that the parental strain YPIII/pIB29MEV harboring either LcrV (pTB7) or PcrV (pLJ33) in trans did induce pores of different sizes, we wanted to determine whether LcrV and PcrV exhibited a preference for native substrates during the translocation process. If this were true, it would offer an alternative explanation as to why PcrV poorly translocated the Yersinia effectors YopE and YopH [5] . We selected the ExoS effector of P. aeruginosa and YopE of Yersinia, because ExoS is efficiently secreted by the TTSS of Y. pseudotuberculosis and shares similar biological features to YopE [23] . yopE and exoS, cloned on the high-copy plasmid pUC19 to give pAF19-Gm (yerA + /yopE + ) or pTS103-Gm (orf1 + /exoS + ), respectively, were introduced into YPIII/pIB29MEV, pTB7 and YPIII/pIB29MEV, pLJ33. We used immunoblotting techniques to confirm YopE and ExoS synthesis and secretion in Yersinia strains grown in Yop-inducing media (data not shown).
To evaluate how efficient YPIII/pIB29MEV, pTB7 and YPIII/ pIB29MEV, pLJ33 were at translocating the YopE and ExoS cytotoxins, we utilized the fact that these translocated substrates both induce a characteristic rounding up of the infected target cells [23, 34] . This is due to actin cytoskeleton disruption, which is caused by their GTPase-activating protein (GAP) activity for the Rho family of GTP-binding proteins [35] . HeLa cell monolayers were infected with YPIII/pIB29MEV, pTB7 or YPIII/ pIB29MEV, pLJ33, synthesizing either YopE (pAF19-Gm) or ExoS (pTS103-Gm) in trans. Phase-contrast light microscopy was used to monitor the cytotoxic response induced by translocated ExoS ( figure 3, top) or YopE (figure 3, bottom) at different time points after infection. Already at 2 h after infection, Y. pseudotuberculosis producing endogenous LcrV or LcrV in trans in combination with either ExoS ( figure 3A and 3D) or YopE (figure 3F and 3I) induced a complete cytotoxic response on infected HeLa cells. At the same time, however, the morphology of HeLa cell monolayers infected with Y. pseudotuberculosis producing PcrV more closely resembled a mock infection (figure 3B and 3C vs. 3E and 3G and 3H vs. 3J). Moreover, full cytotoxicity was markedly delayed, being only observed at 4 h after infection. Of importance, however, we could not detect any difference between the rate of YopE-or ExoS-dependent cytotoxicity induced by either the LcrV-or PcrV-producing strain. This suggests that LcrV and PcrV do not display specificity toward native substrates during the translocation process. As we had expected, strains lacking the essential translocon components YopB [3, 32] and LcrV [10, 36] were unable to translocate either ExoS ( figure 3B and 3C) or YopE ( figure 3G and 3H ), even after extended infection periods and the use of higher multiplicities of infection (data not shown).
Efficient in vivo modification of Ras by ExoS translocated from Y. pseudotuberculosis producing LcrV. Because the lack of substrate specificity displayed by both LcrV and PcrV is an important finding, we clarified this using an independent second enzymatic activity of ExoS involving ADP ribosylation At the indicated time points, the effect of the bacteria on the HeLa cells was recorded by phase-contrast microscopy. Top, Strains expressing the Pseudomonas aeruginosa-derived cytotoxin exoenzyme S (ExoS) in trans from plasmid pTS103-gentamicin (Gm). Bottom, Strains expressing the Yersinia outer protein (Yop) E cytotoxin in trans from pAF19-Gm. Note the extensive rounding up of the ExoS-and YopE-dependent, cytotoxically affected HeLa cells. Shown are phase-contrast images of YPIII/pIB29ME, pTS103-Gm (A); YPIII/pIB29MEB, pTS103-Gm (B); YPIII/pIB29MEV, pTS103-Gm (C); YPIII/pIB29MEV, pTB7, pTS103-Gm (D); YPIII/pIB29MEV, pLJ33, pTS103-Gm (E); YPIII/pIB29ME, pAF19-Gm (F); YPIII/pIB29MEB, pAF19-Gm (G); YPIII/pIB29MEV, pAF19-Gm (H); YPIII/pIB29MEV, pTB7, pAF19-Gm (I); and YPIII/pIB29MEV, pLJ33, pAF19-Gm (J). Scale bar, 20 mm.
toward members of the Ras superfamily of GTPases [37] . Because this activity relies on the eukaryotic 14-3-3 protein family, ExoS-dependent ADP ribosylation of Ras provides a sensitive method for assaying the direct translocation of ExoS into target cells. To assess the level of Ras modification in vivo, HeLa cell monolayers were infected for various times with relevant Yersinia strains. Infected cells were directly harvested in sample buffer on ice, and the lysates were separated by SDS-PAGE, followed by immunoblotting with monoclonal anti-Ras antibody. Yersinia producing endogenous (figure 4, lane a) or in trans ( figure 4, lane d) LcrV required as few as 60 min to translocate sufficient ExoS to ADP ribosylate the total cellular Ras population, as was indicated by a slower mobility on SDS-PAGE. In contrast, at least 2 h were required for Yersinia producing PcrV to induce an ExoS-dependent complete ADP ribosylation of Ras ( figure 4, lane e) . This represents a significant delay in PcrV-mediated translocation, compared with LcrV. As had been expected, bacteria that were defective for either LcrV or YopB were unable to mediate ExoS translocation, and Ras proteins remained unmodified ( figure 4, lanes b and c) . The fact that LcrV could efficiently translocate ExoS confirms that LcrV and PcrV do not exhibit specificity toward native translocated substrates.
Construction and phenotypic analysis of an lcrGVHyopBD operon deletion mutant of Y. pseudotuberculosis. Having established that substrate specificity does not account for the differences in the translocation efficiencies seen for LcrV or PcrV in Yersinia, we decided to investigate whether PcrV requires native proteins encoded by the pcrGVHpopBD translocon operon of P. aeruginosa to form fully functional pores in Yersinia. This possibility was examined by exchanging the entire translocase operon of Yersinia (lcrGVHyopBD) with that of P. 
aeruginosa (pcrGVHpopBD).
We engineered a complete deletion of the Yersinia lcrGVHyopBD operon in which only the first 6 residues of LcrG and the last 3 residues of YopD remained, giving rise to the mutant YPIII/pIB799. Using immunoblotting, we confirmed the loss of YopB, LcrV, YopD, and LcrH in both total and secreted protein fractions derived from the operon mutant ( figure 5A, lanes c and d) . Poor-quality antiserum prevented the confirmation of the expected loss of LcrG. In addition, constitutive synthesis and the secretion of YopH and YopE were observed in the operon mutant (YPIII/pIB799) regardless of inducing (ϪCa 2+ ) or noninducing (+Ca 2+ ) growth conditions, which reflects a loss of yop regulatory control ( figure  5A, lane c vs. lane d) . In contrast, protein production and secretion in the wild-type strain were only induced when grown in medium without Ca 2+ , reflecting normal yop regulatory control ( figure 5A, lane a vs. lane b) . This important regulatory phenotype was further examined by a MOX plating assay. Unlike wild-type Yersinia, the operon null mutant displayed a temperature-sensitive (TS) growth phenotype [8] , consistent with the requirement for LcrG, LcrH, and YopD in the negative regulation of Yop synthesis [28, [38] [39] [40] [41] .
To complement the full-length operon mutant, a pMS9 construct encoding the pcrGVHpopBD operon from P. aeruginosa [17] under control of its native promoter located upstream of pcrG was introduced into YPIII/pIB799. At inducing conditions (without Ca 2+ ), we could confirm the presence of PopB, PcrV, and PopD in both total lysates and the culture supernatant fraction of YPIII/pIB799, pMS9 ( figure 5B, lanes b and d) . The absence of specific antibodies to PcrG and PcrH prevented their visualization. Of interest, high levels of PopB, PcrV, PopD, YopH, and YopE were even observed in cell lysates prepared from bacteria grown in noninducing conditions (with Ca 2+ ) ( figure 5B, lane a vs. lane b) . This result indicates that expression of pcrGVHpopBD is unable to restore the regulatory defect associated with an lcrGVHyopBD mutant of Yersinia, corroborating the TS growth phenotype observed by MOX analysis.
Y. pseudotuberculosis expressing pcrGVHpopBD efficiently translocates Yop effector proteins and forms LcrV-like pores.
Having established the coproduction of PcrV with native translocon components in a suitably engineered strain of Yersinia, we wanted to investigate how efficient the complemented strain YPIII/pIB799, pMS9 was at translocating Yop effector proteins. We used the HeLa cell cytotoxicity assay as a means to study the translocation of the YopE cytotoxin into target cells. As expected, the operon deletion mutant YPIII/pIB799 was unable to translocate YopE into the cytosol of infected HeLa cells (figure 6C vs. 6A), even though secretion was confirmed. In contrast, the wild-type strain induced a dramatic morphological change of the infected HeLa cells ( figure 6B) . Surprisingly, the trans-complemented strain YPIII/pIB799, pMS9 was similar to the wild type in being able to efficiently translocate Yop effectors, as evidenced by the rapid YopE-mediated cytotoxic response ( figure 6D vs. 6B ). This result contrasted with the delayed translocation observed when PcrV alone was expressed in the context of Yersinia translocator proteins (see figures 3 and 4) [5] .
To evaluate whether this efficient translocation was due to an increase in pore size, we examined the trans-complemented operon mutant (YPIII/pIB799, pMS9) in an osmoprotection assay. In so doing, the full-length operon deletion was introduced into the virulence plasmid of YPIII/pIB29MEK. This created an isogenic strain, YPIII/pIB799-29MEK, to enable direct comparisons with the pores formed by other strains used in the present study. The noncomplemented operon mutant was unable to induce pores in the membranes of erythrocytes, which reflects an essential pore-forming function for YopB, YopD, and LcrV ( figure 2D ). In contrast, the operon mutant harboring pcrGVHpopBD (YPIII/pIB799-29MEK, pMS9) showed a strong lytic activity that was an additional 34% higher than that induced . Proteins were separated by SDS-PAGE and identified by immunoblot analysis using polyclonal rabbit anti-YopH, anti-YopB, anti-LcrV, anti-YopD, anti-YopE, anti-LcrH, anti-PopD, or anti-PcrV antisera. Detection of PopB was made using the cross-reactive anti-YopB antisera [15] . Total samples refer to a mixture of proteins secreted into the culture medium and contained within intact bacteria, whereas supernatant samples only contain secreted proteins. by YPIII/pIB29MEK ( figure 2D vs. 2A) . This is not likely to be a consequence of excessive protein pools with which to form more pores, given that Coomassie staining of secreted proteins fractionated by SDS-PAGE indicated that at least PopB and PopD were secreted at lower levels than native YopB and YopD (data not shown). Of importance, the pores induced by this trans-complemented strain were not blocked by the smaller carbohydrates raffinose (1.2-1.4 nm f) or dextrin 15 (2.2 nm f). Only the largest carbohydrate, dextran 4 (3-3.5 nm f), could block these pores ( , 77% reduction) ( figure 2D ). P ! .05 Hence, we conclude that the efficient translocation observed for YPIII/pIB799-29MEK, pMS9 correlated to the formation of larger pores. This strongly suggests that the pores induced by Yersinia producing PcrV together with YopB and YopD are not completely functional pores. In fact, when PcrV is coproduced together with its native translocase partners, PopB and PopD, the physical characteristics of the pores formed in erythrocyte membranes clearly resembled those formed by a complex of LcrV, YopB, and YopD. This suggests that PcrV requires native translocator proteins to fully complement defects in Yersinia Yop effector translocation.
DISCUSSION
The formation of bacterial-induced pores in biological membranes is an essential means for pathogenic bacteria to translocate toxic molecules into host cells [42] . In the present study, we set out to address whether the pore-forming proteins LcrV of Yersinia and PcrV of P. aeruginosa determine translocation efficiencies of antihost effectors into the target cell. We confirmed that the cytotoxins YopE of Yersinia and ExoS of P. aeruginosa were translocated equally well relative to Yersinia producing either LcrV or PcrV. We interpret these data to indicate that neither PcrV nor LcrV favors the translocation of native substrates. As had been seen earlier [5] , we noted that the rate of effector translocation by Yersinia producing PcrV was dramatically delayed. On further investigation of the different pore sizes induced by LcrV and PcrV, we found that a full-translocation operon-deletion mutant (DlcrGVHyopBD) of Y. pseudotuberculosis, when complemented with the corresponding operon (pcrGVHpopBD) of P. aeruginosa, induced larger LcrV-like pores and concomitantly was able to rapidly translocate Yop effectors. Although this confirmed the absence of substrate recognition by LcrV and PcrV, it also illustrated that PcrV requires additional protein(s) from its native translocase operon to efficiently function in Yersinia translocation. Therefore, the reduced PcrV-dependent lysis of infected erythrocytes and the delayed translocation phenotype reported elsewhere [5] was likely due to an inability to form fully functional pores.
The translocation of antihost effectors by TTSS is thought to require the recognition of a signal that predestines a secreted protein for translocation. It follows that all effectors have a modular secondary structure, which includes an N-terminal domain essential for translocation [1, 2] . Even though no consensus sequence within this domain has been demonstrated, a putative recognition mechanism could conceivably occur through either the core secretion components located at the inner face of the cytoplasmic membrane, of which homologues are found in all known TTSS [1] , or after secretion, at the level of the translocon pore. In light of the general promiscuity displayed by TTSS, we considered that the recognition motif might confer a level of substrate specificity that enables endogenous effectors to be translocated more efficiently by their native TTSS. In our hands, however, LcrV and PcrV did not show a preference for translocating either native Yersinia effectors or exogenous ExoS from P. aeruginosa. Although we cannot rule out the presence of an effector specificity signal, the recognition mechanism is clearly not through the LcrV/PcrV component of the translocation pore.
Significantly, the translocation domain also overlaps with a chaperone-binding domain [43] . Bound chaperone is a requirement for the efficient secretion of cognate effector proteins [44] [45] [46] and may impart a specificity signal for translocation. In our study, however, ExoS was coproduced with its native chaperone, Orf1 [23] , which did not alter translocation specificity. However, we note that this domain may simply necessitate the requirement for chaperone binding to prevent premature interactions with other proteins prior to secretion. This was elegantly demonstrated for a YopE mutant lacking the translocation domain, because it was only translocated by a strain of Yersinia enterocolitica that is unable to produce other Yop effectors [47] . Nevertheless, this does not explain why the YopM effector also contains a modular structure that includes a region necessary for translocation but does not require a known chaperone for efficient secretion [48] .
It is noteworthy that specific recognition sequences and/or folding events that enable vast numbers of proteins to be secreted across the bacterial envelope by 1 of 5 secretion pathways (types I-V) have been defined [2, 49, 50] . Some of these secreted proteins also contain varied translocation signals to traverse the eukaryotic membrane. For example, the type I secreted family of RTX repeat toxins contain repetitive motifs thought to insert directly into the host cell plasma membrane [51, 52] , whereas toxins secreted by the type II pathway specifically interact with a target cell receptor to facilitate uptake [53, 54] . Therefore, whether the translocation of type III secreted effectors involves a bona fide translocation motif, as was initially proposed [55] , remains a focus of our research.
Several reasons made a comparative analysis of translocation efficiencies of the YopE and ExoS effectors meaningful. ExoS is readily secreted and translocated by Yersinia [23] . Moreover, both proteins share similar N-terminal domains that exhibit GAP activity toward Rho GTPases. This activity is responsible for actin depolymerization that is a basis for the virulence strategy termed antiphagocytosis [2] . In addition, a modular organization characteristic of effector proteins is also possessed by YopE and ExoS [2, 6] , and their efficient secretion requires a homologous cognate chaperone termed YerA/SycE and Orf1, respectively [23] . We have extended these observations to show that Yersinia is also able to efficiently translocate ExoS at a rate comparable with native effectors such as YopE. This feature, together with the easily quantifiable ADP ribosylating activity of ExoS that is dependent on the cytosolic eukaryotic protein 14-3-3 [36] , makes this protein a sensitive probe for investigating the role of individual proteins in the translocation process.
When PcrV was initially introduced in an lcrV null mutant of Yersinia, significantly smaller pores were formed in infected erythrocytes [5] , which was consistent with findings in the artificial lipid bilayer system [5] . At odds with this was the observation that a PcrV-dependent pore that formed during P. aeruginosa infection of erythrocytes was comparable in size to the pores observed for Yersinia producing LcrV [5, 13] . To resolve this issue, we generated a full-translocase operondeletion mutant of Yersinia complemented with the pcrGVHpopBD operon of P. aeruginosa. When it was used to infect erythrocytes, this strain induced increased lysis with larger pores. In addition, the efficient translocation of Yop effectors was restored, reminiscent to that observed for Yersinia expressing LcrV. This is a significant finding that suggests that a PcrV complex with other native P. aeruginosa components encoded within the pcrGVHpopBD translocase operon are required to form a fully functional pore. Therefore, it would be interesting to analyze whether PcrV purified as a complex with other native components forms larger pores in an artificial bilayer system. Nevertheless, clearly the smaller pores formed when PcrV is produced together with YopB and YopD in Yersinia are likely to be the result of partly nonfunctional interactions between the heterologous translocators.
An analysis of hybrids between LcrV and PcrV revealed a central domain that altered translocation efficiencies in Yersinia [5] . We envisage that such an approach could well identify key LcrV/PcrV domains that promote functional interactions with native translocator components. At least in Yersinia, there is a precedence for LcrV, YopB, and YopD interactions in vitro [56, 57] . Indeed, our preliminary observations analyzing the functional interchangeability between components of the Yersinia and P. aeruginosa translocase operons clearly indicated that some components are only able to promote translocation in the presence of their native partners [18] . In view of this, the translocation process is highly regulated, being fine tuned by the specificity of the interaction partners.
